ReproCELL Incorporated
Provider of stem cell technology and services for research and regenerative medicine.
4978 | T
Overview
Corporate Details
- ISIN(s):
- JP3974770004
- LEI:
- Country:
- Japan
- Address:
- 横浜市港北区新横浜３−８−１１
- Website:
- https://www.reprocell.com/
Description
ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-02-10 07:02 |
四半期報告書－第20期第3四半期(令和3年10月1日－令和3年12月31日)
|
Japanese | ZIP • 192.3 KB | ||
| 2021-11-12 07:04 |
四半期報告書－第20期第2四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | ZIP • 215.0 KB | ||
| 2021-08-13 08:14 |
四半期報告書－第20期第1四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | ZIP • 212.8 KB | ||
| 2021-06-28 08:04 |
確認書
|
Japanese | ZIP • 8.0 KB | ||
| 2021-06-28 08:03 |
内部統制報告書－第19期(令和2年4月1日－令和3年3月31日)
|
Japanese | ZIP • 22.2 KB | ||
| 2021-06-28 08:02 |
有価証券報告書－第19期(令和2年4月1日－令和3年3月31日)
|
Japanese | ZIP • 1.2 MB | ||
| 2021-02-12 07:39 |
四半期報告書－第19期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | ZIP • 173.5 KB | ||
| 2020-11-12 07:29 |
四半期報告書－第19期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | ZIP • 200.1 KB | ||
| 2020-09-29 08:03 |
四半期報告書－第19期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | ZIP • 168.7 KB | ||
| 2020-08-28 02:15 |
確認書
|
Japanese | ZIP • 8.0 KB | ||
| 2020-08-28 02:14 |
内部統制報告書－第18期(平成31年4月1日－令和2年3月31日)
|
Japanese | ZIP • 26.7 KB | ||
| 2020-08-28 02:13 |
有価証券報告書－第18期(平成31年4月1日－令和2年3月31日)
|
Japanese | ZIP • 1.1 MB | ||
| 2020-02-13 07:08 |
四半期報告書－第18期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | ZIP • 168.6 KB | ||
| 2019-11-13 07:11 |
四半期報告書－第18期第2四半期(2019/07/01－2019/09/30)
|
Japanese | ZIP • 204.5 KB | ||
| 2019-08-09 08:05 |
四半期報告書－第18期第1四半期(2019/04/01－2019/06/30)
|
Japanese | ZIP • 164.7 KB |
Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ReproCELL Incorporated
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
